Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Among prominent attendees at this year's conference of the Bilderberg group, a secretive society that includes some of the world's most powerful people: Jacques Aigrain, CEO of Swiss Re. Ahmad Chalabi, former deputy prime minister of Iraq and long-time opponent of Saddam Hussein. George A. David, chairman of Coca-Cola. Paul Desmarais, CEO of Power Corporation. Richard Holbrooke, key American negotiator for 1995 Bosnian peace accords. Vernon Jordan, friend and onetime presidential aide to Bill Clinton. Henry Kissinger, foreign-policy guru and secretary of state under Richard Nixon. Ed Kronenburg, director of NATO's private office. Bernardino Leon Gross, Spain's foreign minister. Ronald S. Lloyd, chairman of Credit Suisse First Boston. Queen Beatrix of The Netherlands. Gordon Nixon, Royal Bank of Canada president, CEO. George Pataki, governor of New York state. Richard Perle, senior foreign policy adviser to U.S. President George W. Bush. David Rockefeller, retired banker, heir to oil fortune. Dennis Ross, former Clinton Mideast negotiator. Giulio Tremonti, VP of Italy's chamber of deputies. James Wolfensohn, U.S. Mideast envoy, former head of the World Bank. Robert Zoellick, deputy U.S. secretary of state.

Note: If the above link fails, click here. For those who know about the pre-war manipulations involving weapons of mass destruction in Iraq, the participation of Ahmed Chalabi speaks volumes. And for a revealing three-minute video clip on CNN about this highly secretive group, click here.

Ottawa. On the outskirts of the nation's capital, a tony high-rise hotel beside a golf course is hosting the annual meeting for one of the world's most secretive and powerful societies. They're called the Bilderberg group. Those who follow the Bilderberg group say it got Europe to adopt a common currency, got Bill Clinton elected after he agreed to support NAFTA, and is spending this week deciding what to do about high oil prices and that pesky fundamentalist president of Iran. The Bilderberg group is a half-century-old organization comprising about 130 of the world's wealthiest and most powerful people. They don't have a website. Bilderberg says the privacy of its meetings helps encourage freewheeling discussion. An unsigned press release...confirmed this year's meeting would deal with energy issues, Iran, the Middle East, terrorism, immigration, Russia, European-American relations and Asia. The 2006 group includes David Rockefeller, Henry Kissinger, Queen Beatrix of Holland, New York Gov. George Pataki, the heads of Coca-Cola, Credit Suisse, the Royal Bank of Canada, cabinet ministers from Spain, Greece and a number of media moguls. The group also includes a pair of prominent figures involved in planning the U.S. invasion of Iraq -- Richard Perle and Ahmad Chalabi. Fellow White House power-players Donald Rumsfeld and Paul Wolfowitz, now head of the World Bank, have spoken to the group in the past. The prime ministers of Britain and Canada -- Tony Blair and Stephen Harper -- have addressed the group before.

Note: For two excellent articles from BBC describing this incredibly powerful, highly secretive group of elites:
http://www.WantToKnow.info/051115secretsocietiesbilderberg

In Northern California's Humboldt County, voters decided by a 55-45 margin that corporations do not have the same rights...as citizens when it comes to participating in local political campaigns. Until Tuesday in Humboldt County, corporations were able to claim citizenship rights, as they do elsewhere in the United States. With the passage of Measure T...voters have signaled that they want out-of-town corporations barred from meddling in local elections. The "Yes on T" campaign was rooted in regard for the American experiment, from...references to Tuesday's election as a modern-day "Boston Tea Party," to the quote from Thomas Jefferson: "I hope we shall crush in its birth the aristocracy of our monied corporations which dare already to challenge our government." Just as Jefferson and his contemporaries were angered by dominance of the affairs of the American colonies by King George III and the British business combines...so Humboldt County residents were angered by the attempts of outside corporate interests to dominate local politics. Humboldt County residents...put Measure T on the ballot, declaring, "Our Founding Fathers never intended corporations to have this kind of power." Let us hope that the spirit of '76 prevailed Tuesday in Humboldt County will spread until that day when American democracy is guided by the will of the people rather than the campaign contribution checks of the corporations that are the rampaging "empires" of our age.

Just how far will corporate lobbyists go to tilt governmental decisions in their favor? Last fall, the U.S. Court of Appeals for the District of Columbia Circuit ruled that the Clean Air Act does not require regulating carbon dioxide emissions that are heating up the planet at an unprecedented rate. It turns out that two of the jurists who helped decide the case -- Chief Judge Douglas H. Ginsburg and Judge David B. Sentelle -- attended a six-day global warming seminar at Yellowstone National Park sponsored by a free-market foundation and featuring presentations from companies with a clear financial interest in limiting regulation. Exxon Mobil Corp. and other large businesses contribute to conservative think tanks to help "educate" federal judges through seminars like the one at Yellowstone. The Code of Conduct for federal judges does not prohibit attending such seminars -- as long as participation does not "cast reasonable doubt on the capacity to decide impartially issues that may come before them." Leaders of Congress and the federal courts seem to recognize that the federal judiciary ought to be out of bounds for lobbyists. Judges are appointed for life, and allowing insider access threatens the integrity of the one branch of government that should stand above politics. Court cases must be won by argument, not by influence, and that means putting a stop to judicial junkets that give one side of the debate an unfair advantage.

Shareholders of Exxon Mobil Corp., whose departing chief executive got a $357 million retirement package, overwhelmingly rejected resolutions to rein in compensation at the company's annual meeting yesterday. Chairman and Chief Executive Officer Rex W. Tillerson said predecessor Lee Raymond deserved a $357 million retirement package that he received in January because he delivered record profits.

Note: So price gouging at the gas pumps brings record oil profits and one of the CEO's responsible gets hundreds of millions of dollars as a retirement gift. What kind of message does that send? Why didn't other major newspapers pick up this little "detail."

The American Diabetes Association...privately enlisted an Eli Lilly & Co. executive to chart its growth strategy. The National Alliance on Mental Illness...lobbies for treatment programs that also benefit its drug-company donors. The National Gaucher Foundation...gets nearly all its revenue from one drugmaker, Genzyme Corp. Many patient groups and drug companies maintain close, multimillion-dollar relationships while disclosing limited or no details about the ties. An Inquirer examination of six groups, each a leading advocate for patients in a disease area, found that the groups rarely disclose such ties when commenting or lobbying about donors' drugs. Combined, the six received at least $29 million from drug companies last year. The amount ranged from 2 percent to 7 percent of revenue at the Arthritis Foundation, to 89 percent to 91 percent at the much smaller National Gaucher Foundation. The funding usually comes from the companies' marketing or sales divisions, not charity offices. Grants often rise with promotional spending as a drug hits the market and fall when sales ebb. Donations from Merck and Pfizer Inc. to the Arthritis Foundation more than doubled, to at least $1.65 million combined, in 2000 as they launched Vioxx and Celebrex. Merck explicitly wove the foundation into sales strategies. In 2000-2001, the American Diabetes Association did not disclose an unusual gift from Lilly: a lent executive, Emerson "Randy" Hall Jr., who moved into its Alexandria, Va., headquarters and coached it on growth strategies, all paid by Lilly.

Note: If you want to understand how the huge pharmaceutical industry influences what you know about their drugs, this article is a must read. You may first want to read a riveting two-page summary of an exposé by the former editor-in-chief of the New England Journal of Medicine, who details major collusion and corruption in the pharmaceutical industry at http://www.WantToKnow.info/healthcoverup

Imagine the dilemma of having so much cash in your bank account that you didn't know what to do with it. This pipe dream for the average American is now reality for the country's biggest corporations. The industrial companies that make up the Standard & Poor's 500 index...have a staggering $643 billion in cash and equivalents. "We're in a time that is out of whack with all historical numbers," said Howard Silverblatt, equity market analyst at Standard & Poor's. "People are demanding why corporations need so much cash, what are they going to do with it?" Companies began propping up their reserves through 16 straight quarters of double-digit profit growth. Leading the pack with the most cash is Exxon Mobil Corp., which has about $36.55 billion on its balance sheet. That amount is nearly equal to its 2005 profit of $36.13 billion, the highest ever for a U.S. company. Some results of the cash riches: An unprecedented $500 billion of stock buybacks. Last year, ExxonMobil spent $18.2 billion buying its shares. One of the biggest avenues in which companies have spent this excess money has been through mergers and acquisitions. Some 75.4 percent of all deals under $1 billion so far this year were done purely with cash.

Note: A Google search reveals that though this Associated Press article was widely picked up by medium-sized newspapers in the U.S., none of the top 10 papers picked it up. The Seattle newspaper above also removed the word "huge" from the title after it was published. $36 billion means that more than $100 for every man, woman, and child in the U.S. went into ExxonMobil profits last year, and another $100 for each person went into their cash reserves. If ExxonMobil and other oil companies have so much extra cash, why are gas prices so high? It's also quite interesting that the advertisements of these mega-corporations continually invite us to go into debt buying their products, while their profits and cash reserves grow ever higher.

Drug companies fund a growing number of the studies in leading psychiatric journals, and drugs fare much better in these company-funded studies than in trials done independently or by competitors, researchers reported Wednesday. About 57% of published studies were paid for by drug companies in 2002, compared with 25% in 1992, says psychiatrist Igor Galynker of Beth Israel Medical Center in New York City. His team looked at clinical research in four influential journals: American Journal of Psychiatry, Archives of General Psychiatry, Journal of Clinical Psychiatry and Journal of Clinical Psychopharmacology. In the report, released at the American Psychiatric Association meeting in Toronto, reviewers did not know who paid for the studies they evaluated, Galynker says. There were favorable outcomes for a medication in about: eight out of 10 studies paid for by the company that makes the drug; five out of 10 studies done with no industry support; three out of 10 studies done by competitors of the firm making the drug. As drug companies increasingly fund research that yields favorable outcomes for their drugs, there may be a built-in bias because journals are reluctant to publish studies with negative or inconclusive findings.

Note: To learn more about the astonishing profits and power of the major drug companies, read our concise summary of a major insider's research at http://www.WantToKnow.info/healthcoverup

President George W. Bush has bestowed on his intelligence czar, John Negroponte, broad authority, in the name of national security, to excuse publicly traded companies from their usual accounting and securities-disclosure obligations. Notice of the development came in a brief entry in the Federal Register, dated May 5, 2006, that was opaque to the untrained eye. Unbeknownst to almost all of Washington and the financial world, Bush and every other President since Jimmy Carter have had the authority to exempt companies working on certain top-secret defense projects from portions of the 1934 Securities Exchange Act. Administration officials told BusinessWeek that they believe this is the first time a President has ever delegated the authority to someone outside the Oval Office. It couldn't be immediately determined whether any company has received a waiver under this provision. The timing of Bush's move is intriguing. On the same day the President signed the memo, Porter Goss resigned as director of the Central Intelligence Agency. Only six days later ... USA Today reported that the National Security Agency had obtained millions of calling records of ordinary citizens provided by three major U.S. phone companies. Negroponte oversees both the CIA and NSA in his role as the administration's top intelligence official. In addition to refusing to explain why Bush decided to delegate this authority to Negroponte, the White House declined to say whether Bush or any other President has ever exercised the authority and allowed a company to avoid standard securities disclosure and accounting requirements.

Note: For many revealing reports on government secrecy from major media sources, click here.

Is there a case for conspiracy theories about 9/11 and the Iraq war? About 10 minutes into the ultra-low-budget documentary 'Loose Change,' now making its way around the Internet, that late, great genius of addled truth-telling, Hunter S. Thompson, is heard giving his gonzo opinion of the way the American press behaved after 9/11. "Well, let's see, 'shamefully' is the word that comes to mind," he says. The kernel of truth in all the conspiracy theories is that the Bush administration's biggest supporters and closest political allies have benefited mightily from its policy of open-ended war. Halliburton, Vice President Dick Cheney's old company -- which is all about both oil and defense -- has seen its stock rise from about $12 a share to about $80 a share under this administration. ExxonMobil, which has contributed mightily to the Republican Party, has seen its stock soar from about $32 to $64 since Bush took office. Share prices in both companies, and in their industries, were plunging before the Bush administration came to office in early 2001. 'Loose Change' doesn't present a plausible case for conspiracy, only a collection of innuendoes. But the invasion of Iraq, well, that's a rather different matter. As a whole raft of books by former members of the administration, Bush admirers and outside analysts have established over the last couple of years, the president and vice president were hell-bent on toppling Saddam Hussein even before September 2001.

Note: Though the author belittles 'Loose Change,' he also makes some great points and alerts people to the fact that this free documentary has gained wide popularity.

Beginning in 1997, Pharmacia, currently a subsidiary of Pfizer, sought to boost its sales of the drug Genotropin. To that end, the company illegally marketed the drug to spur growth in short children and as an anti-aging drug for adults looking for the fountain of youth. In a nutshell, the off-label marketing scheme included direct payments to doctors, all-expense paid junkets for doctors, financial incentives to distributors and phony consultant contracts to funnel payments for the off-label promotion. As a result of the scheme's success, sales of the Genotropin sky-rocketed and over the years, Medicaid and other public healthcare programs paid millions of dollars for its improper use. The full amount of damage to health care programs is not yet known. "But this much is certain," former Pfizer Vice President turned whistleblower, Dr Peter Rost, says, "Pharmacia turned Genotropin into a cash cow by illegally peddling a dangerous drug to make short kids tall and their grandparents young." Genotropin is a man made human growth hormone approved to treat a limited range of hormonal deficiencies. The FDA has never approved the drug to spur growth for children without hormonal deficiencies or to prevent aging. Dr Rost joined Pharmacia in June of 2001 as a VP of Marketing. On May 22, 2003, Dr Rost became aware of the pervasive nature of ongoing illegal activity. [He then] decided to file a lawsuit ... alleging fraud relating to the off-label marketing of Genotropin and delivered a copy of the complaint to the US Attorney's Office on June 4, 2003.

Note: Read an excellent article on Dr. Rost and other major whistleblowers from the pharmaceutical industry.

Vaccine industry officials helped shape legislation behind the scenes that Senate Majority Leader Bill Frist secretly amended into a bill to shield them from lawsuits, according to e-mails obtained by a public advocacy group. E-mails and documents written by a trade group for the vaccine-makers show the organization met privately with Frist's staff and the White House about measures that would give the industry protection from lawsuits filed by people hurt by the vaccines. Frist, along with House Speaker Dennis Hastert, R-Ill., ordered the vaccine liability language inserted in a defense spending bill in December without debate and in violation of usual Senate practice. In a written statement, Frist spokeswoman Amy Call stated that the senator had promised publicly to include the vaccine liability protection in the defense spending bill. She did not address the issue of the influence of industry lobbyists.

Note: For one-paragraph summaries of media articles showing why the vaccine makers want this protection, click here.

High crude oil prices aren't the only reason you're paying $3.15 for a gallon of regular. For America's giant gasoline refiners...this is a golden age. By California state estimates, refinery profit margins have more than doubled in 2006, though that figure doesn't take into account some key expenses. Meanwhile, oil prices have risen by 14 percent. Oil industry critics hunting for proof of price gouging point to refineries' expanding profit margins as evidence. Critics say the companies deliberately closed many U.S. refineries years ago as a way to drive up their margins. The country now has 144 refineries, down from 324 in 1981. "The refining business used to be pretty lousy, but they took very aggressive actions to correct that," said Tyson Slocum, director of the energy program at the Public Citizen watchdog group. "They're choosing not to build new refineries because it's not in their economic interest." Exact profit margins for the industry are difficult to track, because the companies involved don't reveal financial details. The California Energy Commission publishes a loose weekly estimate, measuring the difference between what the state's 21 refineries pay for crude oil and what they charge for their products. Since the start of the year, that figure has jumped 130 percent, from 30 cents for each gallon of finished gasoline to 69 cents last week. During the same time, the price refiners pay for crude oil has increased 14 percent.

The country’s three largest oil and gas companies are expected to report combined first-quarter profits this week in excess of $16 billion, a 19 percent surge from last year. Elected officials are scrambling for ways to assuage angry consumers and businesses. President Bush on Tuesday gave the Environmental Protection Agency the authority to temporarily waive regional clean-fuel regulations to promote greater gasoline-supply flexibility, but members of Congress have other ideas. Some are renewing calls for a windfall profits tax and some want federal regulators to investigate industry consolidation. Still others are threatening hearings and expressing outrage at how the industry invests cautiously in new refining capacity yet rewards its executives lavishly. The combined earnings expected from ConocoPhillips, Exxon Mobil Corp. and Chevron Corp. will be 14 times greater than the combined first-quarter profits of Google Inc., Apple Computer Inc. and Oracle Corp. Analysts say full-year profits for the oil majors are likely to surpass the record-setting earnings of 2005, when Exxon reported a $36.13 billion profit -- the highest ever for a U.S. company.

Every psychiatric expert involved in writing the standard diagnostic criteria for disorders such as depression and schizophrenia has had financial ties to drug companies that sell medications for those illnesses, a new analysis has found. Of the 170 experts in all who contributed to the manual that defines disorders from personality problems to drug addiction, more than half had such ties, including 100 percent of the experts who served on work groups on mood disorders and psychotic disorders. "I don't think the public is aware of how egregious the financial ties are in the field of psychiatry," said Lisa Cosgrove, a clinical psychologist at the University of Massachusetts in Boston. The analysis comes at a time of growing debate over the rising use of medication as the primary or sole treatment for many psychiatric disorders, a trend driven in part by definitions of mental disorders in the psychiatric manual. Cosgrove said she began her research after discovering that five of six panel members studying whether certain premenstrual problems are a psychiatric disorder had ties to Eli Lilly & Co., which was seeking to market its drug Prozac to treat those symptoms. The process of defining such disorders is far from scientific, Cosgrove added: "You would be dismayed at how political the process can be."

We have heard various individual cases of overcharging and fraud by American firms in the reconstruction of Iraq. A year ago, an audit by the inspector general found no evidence of work done or goods delivered on 154 of 198 contracts. Sixty cases of potential swindles are under investigation. Halliburton and its hundreds of millions of dollars of overcharges or baseless costs are well known. But millions more were taken by companies that promised to build or restore libraries or police facilities, or deliver trucks and construction equipment. US government investigators can account for only a third of the $1.5 billion given by the CPA to the interim government and it appears that a substantial portion of the $8 billion given to Iraqi ministries went to "ghost employees." Because of the way the United States set things up after the invasion, contractors are immune from prosecution by Iraqis. This is robbery, not reconstruction. It has been three years and all Iraq has become is a "free-fraud zone," according to one of the attorneys for whistleblowers in Iraqi swindles. Recently, the Army found that Halliburton had $263 million of exaggerated or unexplainable costs on a $2.4 billion no-bid contract, yet still paid Halliburton $253 million of the $263 million.

According to reports published today...healthy people are being turned into patients by drug firms which publicise mental and sexual problems and promote little-known conditions only then to reveal the medicines they say will treat them.The studies, published in a respected medical journal, accuse the pharmaceutical industry of "disease mongering" - a practice in which the market for a drug is inflated by convincing people they are sick and in need of medical treatment. The "corporate-sponsored creation of disease" wastes resources and may even harm people because of the medication they turn to, the researchers add. In 11 papers in the journal Public Library of Science Medicine, experts from Britain, the US and elsewhere argue that new diseases are being defined by specialists who are often funded by the drug industry.According to the researchers, the campaigns boost drug sales by medicalising aspects of normal life.

Note: For more on how the pharmaceutical companies can negatively impact your health and your wallet:
http://www.WantToKnow.info/healthcoverup

Frustrated government auditors pleaded, cajoled and finally threatened Halliburton Co. executives who repeatedly failed to comply with government reporting requirements under a key Iraq contract with a $1.2-billion potential price tag. The 15-page report cites findings by auditors that Halliburton overcharged -- "apparently intentionally" -- on the contract by using hidden calculations, and attempted in one instance to bill the government for $26 million in costs it did not incur. The report blamed the Department of Defense for awarding the contract despite warnings from auditors that Halliburton's cost estimating system had "significant deficiencies." Although federal officials have criticized the company and threatened to cancel its contracts, Halliburton remains the largest private contractor in Iraq. The contract, awarded in January 2004, was one of three Iraq pacts for the company once headed by Vice President Dick Cheney. Although the other two agreements...have faced heavy criticism as no-bid contracts...Tuesday's report was the first to focus on the third Halliburton contract. "You are hereby notified that the government considers that you have universally failed to provide adequate cost information as required under the subject contract," a U.S. contracting officer wrote in an Aug. 28, 2004, letter to an executive of KBR, the Halliburton unit formerly known as Kellogg Brown & Root.

A public already groaning under huge deficits does not need more red ink. An oil industry already rolling in record profits does not need more tax breaks. But both are sure to happen unless some way can be found to claw back from a decade's worth of Congressional and administrative blunders, aggressive lobbying and industry greed. According to a detailed account in Monday's Times...oil companies stand to gain a minimum of $7 billion and as much as $28 billion over the next five years under an obscure provision in last year's giant energy bill that allows companies to avoid paying royalties on oil and gas produced in the Gulf of Mexico. The provision received almost no Congressional debate, in part because Congress was lazy and in part because the provision was misleadingly advertised as cost-free. A court decision in 2003 effectively doubled the amount of oil and gas exempted from royalties. Then the Bush administration offered special exemptions for "deep gas" producers, drilling more than 15,000 feet below the sea bottom. Then came the 2005 energy bill, which essentially locked in the old incentives for five more years.

Among those who worry that hackers might sabotage election tallies, Ion Sancho is something of a hero. The maverick elections supervisor in Leon County, Fla., last year helped show that electronic voting machines from one of the major manufacturers are vulnerable...and would allow election workers to alter vote counts without detection. Now, however, Sancho may be paying an unexpected price for his whistle-blowing: None of the state-approved companies here will sell him the voting machines the county needs. "I believe I'm being singled out for punishment by the vendors," he said. The trouble began last year when Sancho allowed a Finnish computer scientist to test Leon County's Diebold voting machines, a common type that uses an optical scanner to count votes from ballots that voters have marked. Some tests...showed that elections workers could alter the vote tallies by manipulating the removable memory cards in the voting machines, and do so without detection. Last month, California elections officials arranged for experts to perform a similar analysis of the Diebold machines and also found them vulnerable -- noting a wider variety of flaws than Sancho's experts had. A spokesman said Diebold will not sell to Sancho without assurances that he will not permit more such tests, which the company considers a reckless use of the machines.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.